Supriya Lifescience: Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please be informed that the Board of Directors of the Company at its Meeting held on Monday October 28 2024 inter-alia considered and approved the Unaudited Financial Results for the quarter and half year ended September 30 2024.